Literature DB >> 15170448

The potential of positron-emission tomography to study anticancer-drug resistance.

Catharine M L West1, Terry Jones, Pat Price.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15170448     DOI: 10.1038/nrc1368

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  5 in total

1.  Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats.

Authors:  Mario L Fabiilli; Morand R Piert; Robert A Koeppe; Phillip S Sherman; Carole A Quesada; Oliver D Kripfgans
Journal:  Contrast Media Mol Imaging       Date:  2013 Jul-Aug       Impact factor: 3.161

2.  Report of the EORTC-PAMM Meeting, Brussels, 16-18 March 2009: new strategies for a targeted and personalised therapy of cancer.

Authors:  S Camporesi
Journal:  Ecancermedicalscience       Date:  2009-04-02

3.  Drug resistance in cancer.

Authors:  E Yagüe; S Raguz
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

4.  Radiosynthesis and pharmacokinetics of [18F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice.

Authors:  Zhaoshuo Yang; Jianhua Liu; Qingqing Huang; Zhouji Zhang; Jiawei Zhang; Yanjia Pan; Yunke Yang; Dengfeng Cheng
Journal:  Onco Targets Ther       Date:  2017-01-11       Impact factor: 4.147

Review 5.  Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.

Authors:  Jichun Zhou; Jianguo Shen; Benjamin J Seifer; Shaojie Jiang; Ji Wang; Hanchu Xiong; Lingmin Xie; Linbo Wang; Xinbing Sui
Journal:  Oncotarget       Date:  2017-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.